Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to IOM Guidelines for Use of Omics Tests in Clinical Trials Add Rigor to Quality Assurance

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »